期刊文献+

系统性红斑狼疮肺动脉高压63例临床分析 被引量:3

Clinical analysis of pulmonary arterial hypertention in systemic lupus erythamatosus
原文传递
导出
摘要 目的探讨系统性红斑狼疮(SLE)并肺动脉高压(PAH)患者的临床特点、发病机制以及诊治方法,提高对该病的认识。方法选取本院近5年住院的SLE合并PAH的患者63例,对其临床症状、实验室指标、超声心动图特点、SLE病情活动评分等进行回顾性分析。结果该组患者抗RNP抗体阳性率较高,肺动脉压力与SLE病情活动评分无关,PAH的轻重与血液中自身抗体的出现无明显关系,PAH重者易有雷诺现象发生,而且与其他系统受累无关联,比较有无肾脏受累的患者在临床以及实验室指标的不同,没有明显差别。结论SLE患者PAH发生与其他脏器受累无关,发病隐匿,临床上应该重视SLE肺动脉压的筛查,早期发现和治疗以利于病情的控制和改善预后。 Objective To study the clinic manifestrations, mechanism, diagnosis and treatment of pulmonary arterial hypertention (PAH) in systemic lupus erythamatosus (SLE). Methods The clinic symptoms, laboratory tests. Doppler tests of patients who were diagnosed with PAH and SLE during last five years were analyze retrospectively. Results Anti-RNP antibody's prevalence rate was high. The presence of pulmonary arterial perssure (PAP) was not related to SLE disease active index (SLEDAI). Those who had PAP higher than 45 mm Hg were prone to have Raynaud's phenomenon PAH had no association to auto-antibodies and other systemic lesions. There were no differences in clinic features, auto-antibodies and other examinations between those with kidney injure and without kidney injure. Conclusion PAH may develop insidiously in SLE, so early diagnosis and prompt treatment of PAH can improve the prognosis.
出处 《中华风湿病学杂志》 CAS CSCD 2008年第9期626-628,共3页 Chinese Journal of Rheumatology
关键词 红斑狼疮 系统性 高血压 肺性 狼疮 肾炎 Lupus erythematosus, systemic Hypertention, pulmonary Lupus nephritis
  • 相关文献

参考文献12

  • 1David B, Steve H, Gregory S. Medical therapy for pulmonary arterial hypertension. Chest, 2004, 126: 35-62.
  • 2De Papa N, Conforti G, Gambini D, et al. Characterization of the endothelial surface proteins by antiendothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol, 1994, 70: 211-216.
  • 3Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest, 1998, 114: 208-212.
  • 4王文琴,孙凌云,金欧.系统性红斑狼疮合并肺动脉高压患者血浆血管紧张素Ⅱ水平的检测[J].中华风湿病学杂志,2001,5(3):197-198. 被引量:1
  • 5郭强,顾越英,黄文群,杨程德,吴华伟,鲍春德,王元,许建荣,陈顺乐.系统性红斑狼疮患者525例肺部病变的调查[J].中华风湿病学杂志,2004,8(6):363-366. 被引量:29
  • 6Wigley M, Lima JA, Mayes M, et al. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum, 2005, 52: 2125-2132.
  • 7Winslow TM, Ossipow MA, Fazio GP, et al. Five year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J, 1995, 129:510-515.
  • 8Li EK, Tam LS. Pulmonary hypertension in systemic lupus erythematosus: circulation association and survival in 18 patients. J Rheumatol, 1999, 26: 1923-1929.
  • 9Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum, 2003, 48: 516-522.
  • 10Humbert M, Barst R J, Robbins IM, et al. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: breathe-2. Eur Respir J, 2004, 24: 353-359.

二级参考文献38

  • 1罗蔚慈.现代呼吸病学[M].人民军医出版社,1997.612.
  • 2Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The European working party on systemic lupus erythematosus. Medicine (Baltimore), 1993, 72:113-124.
  • 3Arakama H, Yamada H, Kurihara Y, et al. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis:serial high-resolution CT findings and functional correlation. Chest,2003, 123:1096-1103.
  • 4Hochberb MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1997, 40:1725.
  • 5Hawker G, Gabriel S, Bombardier C, et al. A reliability study of SLEDAI:a disease activity index for systemic lupus erythematosus.J Rheumatol, 1993, 20:657-660.
  • 6Mohammed YK, Luis CM, Colin MT, et al. Presentation prognosis of the shrinking lung syndrome in systemic lupus erythematosus.Semin Arthritis Rheum, 2002, 31: 289-298.
  • 7Keane MP, Lynch JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax, 2000, 55:159-166.
  • 8Demedts M, Costabel U. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonia.Eur Respir J, 2002, 19:794-796.
  • 9Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med, 2002, 165:1581-1586.
  • 10Wallace DJ, Hahn BH. Dubois′ lupus erythematosus. 5th. Philadelphia:Lippincott Williams & Wilkins, 1997.19-30.

共引文献62

同被引文献38

  • 1韩扣兰,李荣良,戴小丽,黄诚.系统性红斑狼疮合并肺动脉高压36例临床分析[J].山东医药,2009,49(52):79-80. 被引量:4
  • 2郭强,顾越英,黄文群,杨程德,吴华伟,鲍春德,王元,许建荣,陈顺乐.系统性红斑狼疮患者525例肺部病变的调查[J].中华风湿病学杂志,2004,8(6):363-366. 被引量:29
  • 3Kasparian A, Floros A, Gialafos E, et al. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus,2007,16 (7): 505-508.
  • 4Choojitarom K, Verasertniyom O, Totemehokehyakarn K, et al. Lupus nephritis and Raynaud's factors for vascular thrombosis phenomenon are significant risk in SLE patients with positive antiphospholipid antibodies. Clinical Rheumatology, 2008,27 (3) : 345-351.
  • 5Appenzeller S, Pereira DA, Costallat LT, et al. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Lupus,2008,17( 11 ) : 1023-1028.
  • 6Doria A, Laccarino L Ghirardello A, et al. Long-term prognosis and causes of death in systemic lupus erythematosus.Am J Med, 2006, 119: 700-706.
  • 7Hochberg MC. Updating the American College of Rheumatology revised critera for the classification of systemic lupuserythematosus. Arthritis Rheum, 1997, 40: 1725.
  • 8David B, Steve H, Gregmy S. Medical therapy for pulmonary arterial hypertension. Chest, 2004, 126: 35-62.
  • 9Pan TL, Thumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus, 2000, 9: 338-342.
  • 10Haas C. Pulmonary hypertension assoeiated with systemic lupus erythematosus. Bull Acad Natl Med, 2004, 188: 985-997.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部